Based on these findings, which strongly indicate that MEK5/Erk5 signaling may mediate cancer progression to an aggressive phenotype, we further explored the involvement of MEK5/Erk5 signaling in resistance to apoptosis as well as EMT. The gene discussed is MAP2K5; the disease is cancer.